AuntMinnie

OCTOBER 25, 2024

Who made it to the final round in the 2024 edition of the Minnies, AuntMinnie.com 's event recognizing excellence in radiology? Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. The Minnies finalists were drawn from over 200 candidates across 15 categories.

Nuclear Medicine 358

Nuclear Medicine Education Radiology Technologist Radiation Science 358

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

Imaging Technology

JANUARY 27, 2025

The Care Innovation Hub leverages the strengths of academia and industry to create, evaluate and translate novel technology into a clinical setting with the goals of advancing diagnosis and treatment of disease, improving hospital operations and driving more equitable access to care. tim.hodson Mon, 01/27/2025 - 10:11 Jan.

Healthcare 59

Healthcare Healthcare Magnetic Resonance Imaging Disease 59

AuntMinnie

JANUARY 30, 2024

The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases. Lipton is a professor of radiology at Columbia University’s Vagelos College of Physicians and Surgeons and an affiliate professor of biomedical engineering at Columbia University. "In

MRI 263

MRI Radiopharmaceuticals Disease Imaging 263

Open Medscience

MARCH 22, 2024

Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases. The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiology Disease 52

AuntMinnie

JUNE 10, 2024

The approach may also assist in the early management of patients with advanced, end-stage disease by identifying appropriate treatment regimens and predicting response to therapies, such as radiopharmaceutical therapy.” Automatic cancer detection and characterization can make way for early treatment and better patient outcomes.

Nuclear Medicine 257

Nuclear Medicine Radiopharmaceuticals Imaging Medical Imaging 257

Imaging Technology

MAY 14, 2024

Siemens Healthineers and UH will look to also advance the treatment of patients with Alzheimer’s disease and use theranostics—combining the approaches of diagnostics and therapeutics—to treat patients with advanced forms of certain cancers, as well as develop new magnetic resonance ( MR ) technologies. tesla and 3T scanners.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

Imaging Technology

JUNE 10, 2024

More recently, she and her collaborators developed a PET imaging agent for vaso-occlusive crisis in sickle cell disease, recently approved for human studies by the FDA as an Investigational New Drug. Louis , Missouri, where she worked more than 20 years developing PET and radiopharmaceutical therapy agents.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. Hope, vice chair of clinical operations and strategy in the UCSF department of radiology, established the radioligand therapy group at the university. However, few freestanding theranostics centers exist today. Morris continued in the JNM.

Nuclear Medicine 222

Nuclear Medicine Radiation Oncology Nursing Radiation 222

TRA Medical Imaging

JANUARY 17, 2025

Residency Training: Following medical school, radiologists enter a four-year residency in diagnostic radiology, where they learn to interpret medical images, perform imaging-guided procedures, and provide accurate diagnoses. Interventional Radiology (IR): This sub-specialty focuses on minimally invasive procedures guided by imaging.

Radiologist 52

Radiologist Minimally Invasive Procedure Nuclear Medicine IT 52

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130

Imaging Technology

JUNE 26, 2023

For more than two decades, Mahmood has been involved in the development and implementation of new imaging methods for the examination of disease processes, with a focus on translatable technology and early therapeutic response assessment.

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

Imaging Technology

APRIL 2, 2024

The availability of these offerings – including the MIM SurePlan and MIM Symphony families, MIM Maestro, MIM Encore, and more – is in alignment with GE HealthCare’s precision care strategy, which aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states. "We

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. POSLUMA was developed to assist physicians in the detection and localization of prostate cancer.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

Imaging Technology

OCTOBER 4, 2024

As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown. Dosimetry in Radiopharmaceutical Therapy. J Nucl Med. 2022 Oct;63(10):1467-1474. doi: 10.2967/jnumed.121.262305. 121.262305. [ii]

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

Future Teleradiology

NOVEMBER 27, 2023

Advances in Cardiac Imaging: Precision in Heart Disease Diagnosis: Highlight recent breakthroughs in cardiac imaging within nuclear medicine. Novel Radiopharmaceuticals: Expanding Therapeutic Options: Highlight recent developments in novel radiopharmaceuticals.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Modalities Radiation 52

Imaging Technology

JUNE 20, 2024

When produced in combination with the company’s TRACERcenter – which is designed to serve as a complete PET radiopharmacy solution – the resulting radiopharmaceuticals can help physicians identify and diagnose clinical signs across care areas – including oncology, cardiology, and neurology.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104

Future Teleradiology

NOVEMBER 21, 2023

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclear medicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Advancements in Radiopharmaceuticals: Precision Imaging Agents: Discuss the latest developments in radiopharmaceuticals.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

Imaging Technology

SEPTEMBER 27, 2023

from October 1 to 4, 2023. “PET PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. Gauden , D.Phil., Chief Executive Officer of Blue Earth Diagnostics.

Diagnostic 105

Diagnostic Radiation Oncology Radiation Clinic 105

AuntMinnie

OCTOBER 2, 2024

This year, hundreds of candidates have been selected as semifinalists for 14 categories, ranging from Most Influential Radiology Researcher to Best New Radiology Software. The semifinalist list was compiled based on nominations from members of AuntMinnie.com. Winners will be selected by our expert panel in two rounds of voting.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

AuntMinnie

MARCH 25, 2024

The “hybrid” scan – which combines molecular PET and anatomical CT images – may have its highest potential in visualizing early signs of so-called “perfusion deficits” (regions of obstructed blood flow), said Marcelo Di Carli, MD, a professor of radiology and medicine at Harvard Medical School, in a recent interview with AuntMinnie.com. “[PET/CT]

Nuclear Medicine 321

Nuclear Medicine Radiopharmaceuticals Disease Radiation 321

Global Radiology CME

DECEMBER 21, 2024

A nuclear medicine hepatobiliary scan was also performed (not shown) and demonstrated no radiopharmaceutical present in the gallbladder due to cystic duct obstruction. Interventional approaches to gallbladder disease. A transperitoneal route is favored in patients with coagulopathy or diffuse liver disease [1]. 2022;16(1):49-54.

Education 52

Education Global Radiology Nuclear Medicine Ultrasound 52